NCT02128204View on ClinicalTrials.gov

The Safety and Efficacy of Using HYADERMIS LA for Wrinkle Correction

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

January 31, 2015

Conditions
PainNosalabial Folds Correction
Interventions
DEVICE

lidocaine contained hyaluronate facial dermal filler

HYADERMIS LA Facial Dermal Implant contains 20 mg/ml hyaluronate and 0.3 % lidocaine.

DEVICE

hyaluronate facial dermal filler

Hya-Dermis Facial Dermal Implant contains 20 mg/ml hyaluronate.

Trial Locations (1)

80249

Aesthetic Center of Yuan's General Hospital, Kaohsiung City

All Listed Sponsors
lead

SciVision Biotech Inc.

INDUSTRY

NCT02128204 - The Safety and Efficacy of Using HYADERMIS LA for Wrinkle Correction | Biotech Hunter | Biotech Hunter